McGlynn, Katherine A.

Global burden of primary liver cancer in 2020 and predictions to 2040

Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology

Hepatocellular Carcinoma Treatment and PrognosisGlobal Cancer Incidence and Screening

Cited by 2,197

Global Burden of 5 Major Types of Gastrointestinal Cancer

Arnold, M., Abnet, C. C., Neale, R. E., Vignat, J., Giovannucci, E. L., McGlynn, K. A., & Bray, F. (2020) · Gastroenterology

Global Cancer Incidence and ScreeningColorectal Cancer Screening and Detection

Cited by 2,027

International trends in hepatocellular carcinoma incidence, 1978–2012

Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., Ferlay, J., Valery, P. C., Bray, F., & McGlynn, K. A. (2020) · International Journal of Cancer

Hepatocellular Carcinoma Treatment and PrognosisGlobal Cancer Incidence and Screening

Cited by 594

Detectable clonal mosaicism and its relationship to aging and cancer

Jacobs, K. B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.-J., et al. (2012) · Nature Genetics

Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities

Cited by 589

Racial disparities in incidence and outcome in multiple myeloma: a population-based study

Waxman, A. J., Mink, P. J., Devesa, S. S., Anderson, W. F., Weiss, B. M., Kristinsson, S. Y., McGlynn, K. A., & Landgren, O. (2010) · Blood

Multiple Myeloma Research and TreatmentsGlobal Cancer Incidence and Screening

Cited by 411

Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012

Florio, A. A., Ferlay, J., Znaor, A., Ruggieri, D., Alvarez, C. S., Laversanne, M., Bray, F., McGlynn, K. A., & Petrick, J. L. (2020) · Cancer

Cholangiocarcinoma and Gallbladder Cancer StudiesGlobal Cancer Incidence and Screening

Cited by 304

Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the Liver Cancer Pooling Project

Petrick, J. L., Campbell, P. T., Koshiol, J., Thistle, J. E., Andreotti, G., Beane-Freeman, L. E., Buring, J. E., Chan, A. T., Chong, D. Q., Doody, M. M., et al. (2018) · British Journal of Cancer

Hepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer Studies

Cited by 257

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare

Petrick, J. L., Yang, B., Altekruse, S. F., Van Dyke, A. L., Koshiol, J., Graubard, B. I., & McGlynn, K. A. (2017) · PLOS ONE

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 210

Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study

Welzel, T. M., Mellemkjaer, L., Gloria, G., Sakoda, L. C., Hsing, A. W., Ghormli, L. E., Olsen, J. H., & McGlynn, K. A. (2007) · International Journal of Cancer

Cholangiocarcinoma and Gallbladder Cancer StudiesPediatric Hepatobiliary Diseases and Treatments

Cited by 195

Assay reproducibility of serum androgen measurements using liquid chromatography–tandem mass spectrometry

Trabert, B., Xu, X., Falk, R. T., Guillemette, C., Stanczyk, F. Z., & McGlynn, K. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology

Hormonal and reproductive studiesClinical Laboratory Practices and Quality Control

Cited by 21

Liver Cancer

Thomas London, W., Petrick, J. L., & McGlynn, K. A. (2017) · Oxford Scholarship Online

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

Cited by 4